Chongqing Xishan Science and Technology Co (SHSE:688576) Other Current Liabilities: ¥9.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688576 Chongqing Xishan Science and Technology Co Ltd SHSE:688576
90 GF Score
Price ¥41.79
GF Value ¥54.05
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Chongqing Xishan Science and Technology Co Other Current Liabilities?

Chongqing Xishan Science and Technology Co SHSE:688576 +1.43% 90 Other Current Liabilities is ¥9.9 Mil as of Mar. 2026. GuruFocus rates SHSE:688576 with a GF Score™ of 90/100 and a GF Value™ of ¥54.05 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Chongqing Xishan Science and Technology Co's other current liabilities for the quarter that ended in Mar. 2026 was ¥9.9 Mil.

Chongqing Xishan Science and Technology Co's quarterly other current liabilities declined from Sep. 2025 (¥25.0 Mil) to Dec. 2025 (¥14.9 Mil) and declined from Dec. 2025 (¥14.9 Mil) to Mar. 2026 (¥9.9 Mil).

Chongqing Xishan Science and Technology Co's annual other current liabilities increased from Dec. 2023 (¥6.8 Mil) to Dec. 2024 (¥9.0 Mil) and increased from Dec. 2024 (¥9.0 Mil) to Dec. 2025 (¥14.9 Mil).

Chongqing Xishan Science and Technology Co Other Current Liabilities Related Terms

Chongqing Xishan Science and Technology Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Chongqing Xishan Science and Technology Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Xishan Science and Technology Co Other Current Liabilities Chart

Chongqing Xishan Science and Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.90 16.22 6.84 8.99 14.91

Chongqing Xishan Science and Technology Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.41 26.44 24.98 14.91 9.92
SHSE:688576
90GF Score
Chongqing Xishan Science and Technology Co Ltd SHSE:688576
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Xishan Science and Technology Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ¥9.9 Mil mean?
Chongqing Xishan Science and Technology Co (SHSE:688576) has a Other Current Liabilities of ¥9.9 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chongqing Xishan Science and Technology Co.
Is Chongqing Xishan Science and Technology Co's Other Current Liabilities too high?
Chongqing Xishan Science and Technology Co's current Other Current Liabilities is ¥9.9 Mil. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's Other Current Liabilities compare to ISRG and BDX?
Chongqing Xishan Science and Technology Co's Other Current Liabilities of ¥9.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chongqing Xishan Science and Technology Co. Chongqing Xishan Science and Technology Co's current Other Current Liabilities is ¥9.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥54.05, compared to a current price of ¥41.79 — trading 22.7% below its estimated fair value. The current Other Current Liabilities is ¥9.9 Mil. Chongqing Xishan Science and Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current Other Current Liabilities is ¥9.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?

Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued. The current stock price of ¥41.79 is trading 22.7% below its estimated GF Value™ of ¥54.05. GuruFocus considers Chongqing Xishan Science and Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688576:

  • Other Current Liabilities: ¥9.9 Mil
  • GF Value™: ¥54.05 vs. price of ¥41.79 (22.7% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chongqing Xishan Science and Technology Co Business Description

Address No. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
90GF Score

Get the complete analysis for SHSE:688576

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥41.79
Price
¥54.05
GF Value